Ocugen to Participate in Upcoming November Investor and Industry Conferences
Ocugen announced it will present its modifier gene therapy platform at two November 2026 conferences. CEO Dr. Shankar Musunuri will present at the Stifel 2026 Healthcare Conference in New York on November 12 and join a panel at Cell & Gene Leaders Live 2026 in London on November 15.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.